Laetirobin from the parasitic growth of Laetiporus sulphureus on Robinia pseudoacacia

Journal of Natural Products

Volumn 72, Issue 11, 2009, Pages 1980-1987

  Lear, Martin J ^a   Simon, Oliver ^a   Foley, Timothy L ^b   Burkart, Michael D ^b   Baiga, Thomas J ^c   Noel, Joseph P ^c   DiPasquale, Antonio G ^b   Rheingold, Arnold L ^b   La Clair, James J ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Xenobe Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LAETIROBIN; PLANT EXTRACT; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DIVISION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LAETIPORUS SULPHUREUS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITOSIS; MUSHROOM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ROBINIA PSEUDOACACIA; TREE; X RAY CRYSTALLOGRAPHY; CHEMISTRY; CONFORMATION; CORIOLACEAE; DRUG EFFECT; DRUG SCREENING; FRUITING BODY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE; ROBINIA; STEREOISOMERISM;

LAETIPORUS SULPHUREUS; ROBINIA PSEUDOACACIA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOFURANS; CELL DIVISION; CORIOLACEAE; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; FRUITING BODIES, FUNGAL; MITOSIS; MOLECULAR CONFORMATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ROBINIA; STEREOISOMERISM;

EID: 73349123181     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np9002838     Document Type: Article

References (41)

1. (a) Koehn, F. E.; Carter, G. T. Nat. Rev. Drug Discovery 2004, 4, 206-220.
2. (b) Butler, M. S. Nat. Prod. Rep. 2008, 25, 475-516.
3. (c) Butler, M. S.; Newman, D. J. Prog. Drug. Res. 2008, 65, 3-44.
4. (d) Gordaliza, M. Clin. Transl. Oncol. 2007, 9, 767-776.
5. (e) Kingston, D. G.; Newman, D. J. Curr. Opin. Drug. Discovery Dev. 2005, 8, 207-227.
6. (f) Jones, W. P.; Chin, Y. W.; Kinghorn, A. D. Curr. Drug Targets 2006, 7, 247-264.
7. (a) Adrian, T. E. Curr. Pharm. Des. 2007, 13, 3417-3426.
8. (b) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70, 461-477.
9. (c) Collins, I.; Workman, P. Nat. Chem. Biol. 2006, 2, 689-700.
10. (a) Ryan, R. P.; Germaine, K.; Franks, A.; Ryan, D. J.; Dowling, D. N. FEMS Microbiol. Lett. 2008, 278, 1-9.
11. (b) Zhang, H. W.; Song, Y. C.; Tan, R. X. Nat. Prod. Rep. 2006, 23, 753-771.
12. (c) Gill, M.; Steglich, W. Fortschr. Chem. Org. Naturst. 1987, 51, 1-317.
13. Steinkellner, S.; Lendzemo, V.; Langer, I.; Schweiger, P.; Khaosaad, T.; Toussaint, J. P.; Vierheilig, H. Molecules 2007, 5, 1290-1306.
14. For natural products obtained from L. sulphureus, see: (a) Davoli, P.; Mucci, A.; Schenetti, L.; Weber, R. W. Phytochemistry 2005, 66, 817-823.
15. (b) León, F.; Quintana, J.; Rivera, ?.; Estévez, F.; Bermejo, J. J. Nat. Prod. 2004, 67, 2008-2011.
16. (c) Yoshikawa, K.; Bando, S.; Arihara, S.; Matsumura, E. Chem. Pharm. Bull. 2001, 49, 327-329. The latter reference is particularly relevant, as it identifies a monobenzofuran that exhibited cytotoxicity against Kato III cells.
17. Cochran, K. W. McIlvainea 2000, 14, 34-40.
18. (a) Rodríguez, A. D.; Lear, M. J.; La Clair, J. J. J. Am. Chem. Soc. 2008, 130, 7256-7258.
19. (b) Hughes, C. C.; MacMillan, J. B.; Gaudêncio, S. P.; Fenical, W.; La Clair, J. J. Angew. Chem., Int. Ed. 2009, 48, 728-732.
20. Alexander, M. D.; Burkart, M. D.; Leonard, M. S.; Portonovo, P.; Liang, B.; Ding, X.; Joullie, M. M.; Gulledge, B. M.; Aggen, J. B.; Chamberlin, A. R.; Sandler, J.; Fenical, W.; Cui, J.; Gharpure, S. J.; Polosukhin, A.; Zhang, H. R.; Evans, P. A.; Richardson, A. D.; Harper, M. K.; Ireland, C. M.; Vong, B. G.; Brady, T. P.; Theodorakis, E. A.; La Clair, J. J. ChemBioChem 2006, 7, 409-416.
21. Schorl, C.; Sedivy, J. M. Methods 2007, 41, 143-150.
22. Jackman, J.; O'Connor, P. M. Curr. Protoc. Cell. Biol. 2001, 8.3, 1-20.
23. Although sufficient for guiding the isolation of 1, this process failed to provide sufficient quantities of probe 3 for characterization by NMR analysis. As probe 3 was unnecessary for this study, we did not prepare samples for structural assignment. Efforts are ongoing to apply IAFlabeling methods to develop active probes for molecular and cellular studies as well as to define the structure-activity relationships of 1. These efforts will be reported in due course.
24. The 1024 m/z peak identified from probe 3 during reverse-affinity purification was used to guide preparative isolation of compound 1 (steps h-m, Figure 1). For procedures for DCVC, see: Pedersen, D. S.; Rosenbohm, C. Synthesis 2001, 16, 2431-2434.
25. The use of H/C ratios to determine the applicability of NMR methods was first described by: Crews, P. US-Japan Conference on Marine Natural Products Chemistry (June 2007).
26. Goel, A.; Dixit, M. Synlett 2004, 11, 1990-1994.
27. (a) Wolf, D. E. Methods Cell Biol. 2007, 81, 63-91.
28. (b) Jonker, A.; Geerts, W. J.; Chieco, P.; Moorman, A. F.; Lamers, W. H.; Van Noorden, C. J. Histochem. J. 1997, 29, 347-364.
29. Lemieux, B.; Percival, M. D.; Falgueyret, J. P. Anal. Biochem. 2004, 327, 247-251.
30. Bicamumpaka, C.; Page, M. Int. J. Mol. Med. 1998, 2, 161-165.
31. Verderame, M.; Alcorta, D.; Egnor, M.; Smith, K.; Pollack, R. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 6624-6628.
32. For recent perspectives on antimitotic agents, see: (a) Jackson, J. R.; Patrick, D. R.; Dar, M. M.; Huang, P. S. Nat. Rev. Cancer 2007, 7, 107-117.
33. (b) Ruchaud, S.; Carmena, M.; Earnshaw, W. C. Nat. Rev. Mol. Cell Biol. 2007, 8, 798-812.
34. (c) Ivachtchenko, A. V.; Kiselyov, A. S.; Tkachenko, S. E.; Ivanenkov, Y. A.; Balakin, K. V. Curr. Cancer Drug Targets 2007, 7, 766-784.
35. (d) Weaver, B. A. A.; Cleveland, D. W. Cancer Cell. 2005, 8, 7-12.
36. Benzofuran-containing natural products have been observed in fungi; see: (a) Manniche, S.; Sprogøe, K.; Dalsgaard, P. W.; Christophersen, C.; Larsen, T. O. J. Nat. Prod. 2004, 67, 2111.
37. However, they are more commonly obtained from plant extracts. For recent examples describing the isolation of benzofuran-containing natural products from plants, see: (b) Shen, H.; Hou, A. J. Nat. Prod. Res. 2008, 22, 1451-1456.
38. (c) Chen, T. H.; Liau, B. C.; Wang, S. Y.; Jong, T. T. Planta Med. 2008, 74, 1806-1811.
39. (d) Ross, S. A.; Rodríguez-Guzmán, R.; Radwan, M. M.; Jacob, M.; Ding, Y.; Li, X. C.; Ferreira, D.; Manly, S. P. J. Nat. Prod. 2008, 71, 1764-1767.
40. We have recently completed a total synthesis of (±)-laetirobin (1) that suggests that the biosynthesis arises through a homodimeric Diels - Alder cycloaddition; see: Simon, O.; Reux, B., La Clair, J. J.; Lear, M. J. Chem Asian J., in review.
41. Sapan, C. V.; Lundblad, R. L.; Price, N. C. Biotechnol. Appl. Biochem. 1999, 29, 99-108.